Wordt geladen...
Lenalidomide therapy in treatment refractory cutaneous lupus erythematosus: Histologic and circulating leukocyte profile and potential risk of a systemic lupus flare
BACKGROUND: Lenalidomide is a thalidomide analogue that may serve as an adjunctive therapy for treatment refractory cutaneous lupus erythematosus (CLE). OBJECTIVES: We evaluate the use of lenalidomide in CLE and describe the skin and circulating leukocyte profile of treatment refractory patients bef...
Bewaard in:
| Hoofdauteurs: | , , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2011
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3306524/ https://ncbi.nlm.nih.gov/pubmed/21821308 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaad.2011.01.015 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|